Skip to main content
. 2002 Jan;86(1):91–96. doi: 10.1136/bjo.86.1.91

Table 1.

Affected members of family A

Visual acuity
No Sex Age Age of onset RE LE Funduscopy Fluorescein angiography Diagnosis
III-9 F 65 40 0.5 CF Atrophy of the RPE in the posterior pole. Numerous drusen in this region, centrally the drusen are larger. Circumscribed hyperfluorescence in the posterior pole and relative hypofluorescence at the foveal region. CACD with drusen
III-10 F 65 43 CF 0.16 Atrophy of the RPE in the posterior pole. Fewer drusen compared with her twin sister II-10, the more centrally located drusen are larger. Circumscribed hyperfluorescence in the posterior pole and relative hypofluorescence at the foveal region. CACD with drusen
III-13 F 63 60 0.5 0.5 The area of atrophy of the RPE is smaller compared with II-10 and II-11. Only a few drusen. Circumscribed hyperfluorescence in the posterior pole and relative hypofluorescence at the foveal region. CACD with drusen
IV-1 F 47 No symptoms 1.0 0.8 Small yellow grey spots at the macula, one in the right eye and two in the left eye. No drusen. Small lesions with a hyperfluorescent rim and hypofluorescent centre. These lesions correspond with the spots observed with funduscopy. Probably early CACD
IV-2 F 46 No symptoms 1.0 0.8 Some drusen, most noticeable in the right eye. No abnormalities except two lightly hyperfluorescent spots in het macula of the right eye. Early CACD with few drusen
IV-3 M 45 No symptoms 1.25 1.0 Very discrete perifoveal mottling at the level of the RPE. Slight hyperfluorescent lesions perifoveal in both eyes, more obvious with fluorescein angiography compared with funduscopy. Probably early CACD
IV-4 M 44 No symptoms 1.0 1.0 Discrete perifoveal granular pigmentation at the level of the RPE. Some small drusen. Hyperfluorescent lesions surrounding the fovea. Comparable with III-3 but more extensive. Early CACD with drusen
IV-5 M 40 No symptoms 1.25 1.25 Very discrete perifoveal mottling at the level of the RPE. Discrete hyperfluorescent lesions perifoveally. Probably early CACD
IV-6 M 37 No symptoms 1.0 1.0 No abnormalities. No abnormalities. No funduscopic indication of CACD
IV-8 M 42 No symptoms 0.8 0.8 Drusen and irregular atrophy of the RPE in the macular area. Early and irregular hyperfluorescence in the early phases of the fluorescein angiogram corresponding with the area of atrophy described on funduscopy. No leakage in later phases. CACD with drusen
IV-10 F 40 No symptoms 1.0 1.0 Irregular atrophy of the RPE in de macular area. Some small drusen. Early and irregular hyperfluorescence in the early phases of the fluorescein angiogram corresponding with the area of atrophy described on funduscopy. No leakage in later phases. CACD with drusen
IV-11 M 39 35 0.8 0.8 Irregular atrophy of the RPE surrounding the fovea. A few small drusen. Early and irregular hyperfluorescence in the early phases of the fluorescein angiogram corresponding with the area of atrophy described on funduscopy. No leakage in later phases. Early CACD with drusen
IV-12 M 38 No symptoms 1.25 1.25 Mild RPE changes in a granular pattern surrounding the fovea. Early stages of III-8, 10, and 11. Some drusen Very mild focal hyperfluorescence corresponding with the RPE changes seen on funduscopy. Early CACD with drusen